Cargando…

Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus

This study aimed to define patients with renal cell cancer and coexisting tumor thrombus in order to address concerns regarding survival and prognostic factors after radical surgery. Several prognostic factors for overall survival (OS) were assessed in patients treated surgically at five institution...

Descripción completa

Detalles Bibliográficos
Autores principales: Zapała, Łukasz, Sharma, Sumit, Kunc, Michał, Zapała, Piotr, Kłącz, Jakub, Korczyński, Piotr, Lipowski, Michał, Późniak, Michał, Suchojad, Tomasz, Drewa, Tomasz, Matuszewski, Marcin, Radziszewski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432091/
https://www.ncbi.nlm.nih.gov/pubmed/34501296
http://dx.doi.org/10.3390/jcm10173852
_version_ 1783751083530649600
author Zapała, Łukasz
Sharma, Sumit
Kunc, Michał
Zapała, Piotr
Kłącz, Jakub
Korczyński, Piotr
Lipowski, Michał
Późniak, Michał
Suchojad, Tomasz
Drewa, Tomasz
Matuszewski, Marcin
Radziszewski, Piotr
author_facet Zapała, Łukasz
Sharma, Sumit
Kunc, Michał
Zapała, Piotr
Kłącz, Jakub
Korczyński, Piotr
Lipowski, Michał
Późniak, Michał
Suchojad, Tomasz
Drewa, Tomasz
Matuszewski, Marcin
Radziszewski, Piotr
author_sort Zapała, Łukasz
collection PubMed
description This study aimed to define patients with renal cell cancer and coexisting tumor thrombus in order to address concerns regarding survival and prognostic factors after radical surgery. Several prognostic factors for overall survival (OS) were assessed in patients treated surgically at five institutions from 2012 to 2018. Univariate and multivariate analyses were used to determine the independent risk factors of OS. A total of 142 patients were eligible for further analysis (mean age of 64.75 years, 56% males). Most patients presented with clear cell carcinoma (95%). The Mayo stage was predominantly 0–1 (88%). Distant visceral metastases at the time of diagnosis were present in 36 patients (25%), whereas nodal metastases were present in 24 patients (16.9%). During the follow-up period (mean of 32.5 months), the 3-year OS rate reached 68.2%. The majority of patients received no adjuvant treatment (n = 107). In a multivariable model predicting OS, regional lymph node status (p < 0.001), distant metastases (p = 0.009), tumor grade (p = 0.002), duration of hospitalization (p = 0.016), and Clavien–Dindo grade (p = 0.047) were identified as independent prognostic factors. A subgroup of patients with specific clinicopathological factors may benefit most from the radical surgery, including patients without regional lymph node or distant metastases and with low tumor grades, whereas short hospitalization and low Clavien–Dindo grades represent additional independent prognostic factors.
format Online
Article
Text
id pubmed-8432091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84320912021-09-11 Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus Zapała, Łukasz Sharma, Sumit Kunc, Michał Zapała, Piotr Kłącz, Jakub Korczyński, Piotr Lipowski, Michał Późniak, Michał Suchojad, Tomasz Drewa, Tomasz Matuszewski, Marcin Radziszewski, Piotr J Clin Med Article This study aimed to define patients with renal cell cancer and coexisting tumor thrombus in order to address concerns regarding survival and prognostic factors after radical surgery. Several prognostic factors for overall survival (OS) were assessed in patients treated surgically at five institutions from 2012 to 2018. Univariate and multivariate analyses were used to determine the independent risk factors of OS. A total of 142 patients were eligible for further analysis (mean age of 64.75 years, 56% males). Most patients presented with clear cell carcinoma (95%). The Mayo stage was predominantly 0–1 (88%). Distant visceral metastases at the time of diagnosis were present in 36 patients (25%), whereas nodal metastases were present in 24 patients (16.9%). During the follow-up period (mean of 32.5 months), the 3-year OS rate reached 68.2%. The majority of patients received no adjuvant treatment (n = 107). In a multivariable model predicting OS, regional lymph node status (p < 0.001), distant metastases (p = 0.009), tumor grade (p = 0.002), duration of hospitalization (p = 0.016), and Clavien–Dindo grade (p = 0.047) were identified as independent prognostic factors. A subgroup of patients with specific clinicopathological factors may benefit most from the radical surgery, including patients without regional lymph node or distant metastases and with low tumor grades, whereas short hospitalization and low Clavien–Dindo grades represent additional independent prognostic factors. MDPI 2021-08-27 /pmc/articles/PMC8432091/ /pubmed/34501296 http://dx.doi.org/10.3390/jcm10173852 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zapała, Łukasz
Sharma, Sumit
Kunc, Michał
Zapała, Piotr
Kłącz, Jakub
Korczyński, Piotr
Lipowski, Michał
Późniak, Michał
Suchojad, Tomasz
Drewa, Tomasz
Matuszewski, Marcin
Radziszewski, Piotr
Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
title Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
title_full Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
title_fullStr Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
title_full_unstemmed Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
title_short Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
title_sort analysis of clinicopathological factors influencing survival in patients with renal cell carcinoma and venous tumor thrombus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432091/
https://www.ncbi.nlm.nih.gov/pubmed/34501296
http://dx.doi.org/10.3390/jcm10173852
work_keys_str_mv AT zapałałukasz analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT sharmasumit analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT kuncmichał analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT zapałapiotr analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT kłaczjakub analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT korczynskipiotr analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT lipowskimichał analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT pozniakmichał analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT suchojadtomasz analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT drewatomasz analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT matuszewskimarcin analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus
AT radziszewskipiotr analysisofclinicopathologicalfactorsinfluencingsurvivalinpatientswithrenalcellcarcinomaandvenoustumorthrombus